Show:
- Latest 6 months
- 2019
- 2018
- 2017
- 2016
Loading...
-
Orexo’s closest upcoming presentations at conferencesMay 17 2019
-
Invitation to presentation of Orexo´s Q1 2019 Interim Report, on May 2Apr 30 2019
-
Issues of shares following the vesting of 2016/2019 incentive planApr 26 2019
-
Report from Orexo AB’s annual general meetingApr 11 2019
-
Orexo´s partner Gesynta Pharma secures 6 MEUR in financing round led by IndustrifondenApr 4 2019
-
District Court of Delaware rules that Actavis does not infringes with their Suboxone® and Subutex® genericsMar 29 2019
-
Invitation to presentation of Orexo´s Full Year Report incl. Q4 2018, on January 30Jan 22 2019
-
Actavis infringes Orexo’s long term Zubsolv® US patent ´330Jan 11 2019
